289
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

An evaluation of enasidenib for the treatment of acute myeloid leukemia

, , , , &
Pages 1935-1942 | Received 23 May 2019, Accepted 07 Aug 2019, Published online: 27 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Felicetto Ferrara & Alessandra Picardi. (2020) Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation?. Expert Review of Hematology 13:2, pages 99-108.
Read now

Articles from other publishers (4)

Muhammad Imran Ali & Muhammad Moazzam Naseer. (2023) Recent biological applications of heterocyclic hybrids containing s -triazine scaffold . RSC Advances 13:43, pages 30462-30490.
Crossref
Amr Elagamy, Laila K. Elghoneimy & Reem K. Arafa. 2023. Recent Developments in the Synthesis and Applications of Pyridines. Recent Developments in the Synthesis and Applications of Pyridines 375 410 .
Hanif Ullah, Baoyun Zhang, Narendra Kumar Sharma, Pierre D. McCrea & Yogesh Srivastava. (2022) In-silico probing of AML related RUNX1 cancer-associated missense mutations: Predicted relationships to DNA binding and drug interactions. Frontiers in Molecular Biosciences 9.
Crossref
Gabriela L. Oliveira, Ana R. Coelho, Ricardo Marques & Paulo J. Oliveira. (2021) Cancer cell metabolism: Rewiring the mitochondrial hub. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1867:2, pages 166016.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.